comparemela.com

Latest Breaking News On - Chris garabedian - Page 4 : comparemela.com

Emerging biotech | BioPharma Dive

BioPharma

Simon harnestTodd foleyLyell immunopharmaTodd berryJerel davisMichael yeeOtello stampacchiaChris garabedianMichael gilmanAtlas ventureArrakis therapeuticsSana biotechnologyMitchell bloomJordan saxeArch venture partnersFlagship pioneering

Surf s up: Startup stoked as Chris Garabedian fund funnels cash into ultra-rapid insulin program

Surf Bio’s polymer-based drug delivery platform has caught the eye of some storied VCs.

Stanford universityDrug deliveryChris garabedianDrug deliveryFierce pharma homepage

PolyCore Therapeutics Secures Seed Financing to Address Motor Symptoms and Dyskinesia Associated with Parkinson s Disease

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesChris cashmanKelly beckJim harrisHelena leslieChris garabedianSusanna harrisFred calloriBen franklin technology partnersPolycore therapeutics incBen franklin technology partners of southeastern pennsylvaniaCorporate development at xontogenyPeregrine communicationsCore therapeuticsSoutheastern pennsylvaniaChief executive officer

VivoSense Closes $25M Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Lance myersTanja doweDudley tabakinChris garabedianVivosense incDebiopharm innovation fundNewport beachPerceptive xontogeny ventureDebiopharm innovation

Debiopharm International SA: VIVOSENSE ANNOUNCES CLOSING OF $25M SERIES A FINANCING

Proceeds to accelerate the collection and use of wearable sensor data in clinical trials along with the development of novel digital biomarkers Funding round co-led by the Perceptive Xontogeny

Tanja doweLance myersRachel ford hutmanPatrick morrowKostenloser wertpapierhandelDudley tabakinChris garabedianPatrick hankeyHead of communicationsPrnewswire vivosense incFund contactVivosense incFund is perceptive advisorBusiness developmentDebiopharm innovation fundPerceptive xontogeny venture

vimarsana © 2020. All Rights Reserved.